TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $108,000 | +125.0% | 3,400 | +88.9% | 0.01% | +133.3% |
| Q1 2022 | $48,000 | -28.4% | 1,800 | -10.0% | 0.00% | 0.0% |
| Q4 2021 | $67,000 | -51.8% | 2,000 | -4.8% | 0.00% | -50.0% |
| Q3 2021 | $139,000 | -14.7% | 2,100 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $163,000 | – | 2,100 | -60.4% | 0.01% | – |
| Q1 2021 | $0 | -100.0% | 5,300 | +1666.7% | 0.00% | – |
| Q4 2020 | $6,000 | -76.9% | 300 | -50.0% | 0.00% | -100.0% |
| Q1 2020 | $26,000 | -29.7% | 600 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $37,000 | +428.6% | 600 | +100.0% | 0.00% | +100.0% |
| Q3 2019 | $7,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |